Shaliny Kushwaha
Company: Crossbow Therapeutics, Inc
Job title: Senior Vice President, Regulatory Affairs & Development Operations
Seminars:
CROSSCHECK-101: Accelerating Phase 1 Development for a Novel T-cell Engager in Relapsed or Refractory Hematologic Malignancies 11:30 am
Leveraging forward-thinking dose-finding strategies, including quantitative-systemspharmacology modeling to inform the starting dose Designing an innovative trial to expedite escalation while balancing optimal characterization of a recommended phase 2 dose and mitigation strategies for cytokine release syndrome Developing early clinical development strategies to maximize meaningful collection of safety and preliminary efficacy in a phase 1 settingRead more
day: Day 1